Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CPPED1 mRNA] | CTD | PMID:31150632 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPPED1 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CPPED1 mRNA | CTD | PMID:33387578 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of CPPED1 gene | CTD | PMID:31601247 | aflatoxin B1 | affects expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CPPED1 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CPPED1 mRNA | CTD | PMID:21641981 | aflatoxin B1 | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of CPPED1 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CPPED1 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CPPED1 mRNA | CTD | PMID:33167477 | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of CPPED1 mRNA | CTD | PMID:18355885 | amitriptyline | affects expression | EXP | | 6480464 | Amitriptyline affects the expression of CPPED1 mRNA | CTD | PMID:18355885 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of CPPED1 mRNA | CTD | PMID:30779732 | arsenite(3-) | increases methylation | ISO | CPPED1 (Homo sapiens) | 6480464 | arsenite results in increased methylation of CPPED1 promoter | CTD | PMID:23974009 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CPPED1 gene | CTD | PMID:28931070 and PMID:35440735 | benzo[a]pyrene | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CPPED1 mRNA | CTD | PMID:20064835 and PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | Cpped1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of CPPED1 exon and Benzo(a)pyrene results in increased methylation of CPPED1 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CPPED1 mRNA | CTD | PMID:19770486 and PMID:22610609 | benzo[b]fluoranthene | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of CPPED1 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CPPED1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Cpped1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CPPED1 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CPPED1 mRNA | CTD | PMID:29275510 | Bisphenol B | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of CPPED1 protein | CTD | PMID:34186270 | cadmium dichloride | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of CPPED1 protein | CTD | PMID:24527689 | carbamazepine | affects expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of CPPED1 mRNA | CTD | PMID:25979313 | cisplatin | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CPPED1 mRNA | CTD | PMID:27594783 | clomipramine | affects expression | EXP | | 6480464 | Clomipramine affects the expression of CPPED1 mRNA | CTD | PMID:18355885 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CPPED1 mRNA | CTD | PMID:24386269 | cobalt dichloride | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CPPED1 mRNA | CTD | PMID:19320972 | copper(II) sulfate | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CPPED1 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CPPED1 mRNA | CTD | PMID:20106945 and PMID:25562108 | dibenz[a,h]anthracene | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | entinostat | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | entinostat results in increased expression of CPPED1 mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CPPED1 protein | CTD | PMID:23301498 | epoxiconazole | decreases expression | ISO | Cpped1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CPPED1 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | Cpped1 (Mus musculus) | 6480464 | Ethanol affects the splicing of CPPED1 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of CPPED1 mRNA | CTD | PMID:24136188 | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of CPPED1 mRNA | CTD | PMID:23962444 | folic acid | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | Folic Acid results in increased expression of CPPED1 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CPPED1 mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of CPPED1 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CPPED1 mRNA | CTD | PMID:33387578 | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of CPPED1 mRNA | CTD | PMID:24136188 | imipramine | affects expression | EXP | | 6480464 | Imipramine affects the expression of CPPED1 mRNA | CTD | PMID:18355885 | ketoconazole | affects expression | EXP | | 6480464 | Ketoconazole affects the expression of CPPED1 mRNA | CTD | PMID:18355885 | lipopolysaccharide | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CPPED1 mRNA | CTD | PMID:35811015 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of CPPED1 mRNA | CTD | PMID:30467583 | methidathion | decreases expression | ISO | Cpped1 (Mus musculus) | 6480464 | methidathion results in decreased expression of CPPED1 mRNA | CTD | PMID:34813904 | methotrexate | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CPPED1 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of CPPED1 mRNA | CTD | PMID:23649840 | nickel atom | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CPPED1 mRNA | CTD | PMID:23195993 | nickel sulfate | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of CPPED1 mRNA | CTD | PMID:22714537 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CPPED1 mRNA | CTD | PMID:25729387 | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of CPPED1 mRNA | CTD | PMID:27638505 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CPPED1 mRNA | CTD | PMID:33387578 | resveratrol | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CPPED1 mRNA | CTD | PMID:23557933 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CPPED1 mRNA | CTD | PMID:28374803 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CPPED1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CPPED1 mRNA | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of CPPED1 mRNA | CTD | PMID:25351596 | sodium arsenite | increases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CPPED1 mRNA | CTD | PMID:22714537 | sodium arsenite | affects methylation | ISO | CPPED1 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of CPPED1 gene | CTD | PMID:28589171 | sodium fluoride | increases expression | ISO | Cpped1 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of CPPED1 protein | CTD | PMID:28918527 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of CPPED1 mRNA | CTD | PMID:19281266 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CPPED1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Cpped1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CPPED1 mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CPPED1 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CPPED1 mRNA | CTD | PMID:23411599 and PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CPPED1 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CPPED1 mRNA | CTD | PMID:33387578 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of CPPED1 mRNA | CTD | PMID:30589522 | valproic acid | affects expression | ISO | Cpped1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CPPED1 mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | CPPED1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CPPED1 mRNA | CTD | PMID:29154799 | |